A Special Counsel in Covington’s Chambers top-ranked Food, Drug & Device Practice Group, Christina Kuhn helps medical device, life sciences and technology companies navigate FDA regulation and compliance across the product lifecycle. She advises clients on go-to-market strategies, including on regulatory classification, clinical development, FDA engagement, and marketing claims, with a focus on innovative technologies, such as AI-enabled digital health tools. For commercialized products, Christina counsels on ongoing compliance with FDA postmarket requirements and on strategic responses to enforcement actions. A frequent contributor to Covington’s Digital Health blog, she provides insight on practical implications of FDA’s evolving policies and guidances.